Literature DB >> 18378365

The relative immunogenicity of DNA vaccines delivered by the intramuscular needle injection, electroporation and gene gun methods.

Shixia Wang1, Chunghua Zhang, Lu Zhang, Jun Li, Zuhu Huang, Shan Lu.   

Abstract

Immunogenicity of DNA vaccines varies significantly due to many factors including the inherent immunogenicity of the protein antigen encoded in the DNA vaccine, the optimal immune responses that can be achieved in different animal models and in humans with different genetic backgrounds and, to a great degree, the delivery methods used to administer the DNA vaccines. Based on published results, only the gene gun-mediated delivery approach has been able to elicit protective levels of immune responses in healthy, adult volunteers by DNA immunization alone without the use of another vaccine modality as a boost. Recent results from animal studies suggest that electroporation is also effective in eliciting high level immune responses. However, there have been no reports to identify the similarities and differences between these two leading physical delivery methods for DNA vaccines against infectious disease targets. In the current study, we compared the relative immunogenicity of a DNA vaccine expressing a hemagglutinin (HA) antigen from an H5N1 influenza virus in two animal models (rabbit and mouse) when delivered by either intramuscular needle immunization (IM), gene gun (GG) or electroporation (EP). HA-specific antibody, T cell and B cell responses were analyzed. Our results indicate that, overall, both the GG and EP methods are more immunogenic than the IM method. However, EP and IM stimulated a Th-1 type antibody response and the antibody response to GG was Th-2 dominated. These findings provide important information for the further selection and optimization of DNA vaccine delivery methods for human applications.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18378365      PMCID: PMC2790191          DOI: 10.1016/j.vaccine.2008.02.033

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  75 in total

1.  Electroporation and electrophoretic DNA transfer into cells. The effect of DNA interaction with electropores.

Authors:  S I Sukharev; V A Klenchin; S M Serov; L V Chernomordik
Journal:  Biophys J       Date:  1992-11       Impact factor: 4.033

Review 2.  The role of particle-mediated DNA vaccines in biodefense preparedness.

Authors:  Hansi J Dean; Joel Haynes; Connie Schmaljohn
Journal:  Adv Drug Deliv Rev       Date:  2005-04-12       Impact factor: 15.470

3.  Hemagglutinin (HA) proteins from H1 and H3 serotypes of influenza A viruses require different antigen designs for the induction of optimal protective antibody responses as studied by codon-optimized HA DNA vaccines.

Authors:  Shixia Wang; Jessica Taaffe; Christopher Parker; Alicia Solórzano; Hong Cao; Adolfo García-Sastre; Shan Lu
Journal:  J Virol       Date:  2006-09-20       Impact factor: 5.103

Review 4.  Electroporation of cell membranes.

Authors:  T Y Tsong
Journal:  Biophys J       Date:  1991-08       Impact factor: 4.033

5.  In vivo electrically mediated protein and gene transfer in murine melanoma.

Authors:  M P Rols; C Delteil; M Golzio; P Dumond; S Cros; J Teissie
Journal:  Nat Biotechnol       Date:  1998-02       Impact factor: 54.908

6.  High-efficiency gene transfer into skeletal muscle mediated by electric pulses.

Authors:  L M Mir; M F Bureau; J Gehl; R Rangara; D Rouy; J M Caillaud; P Delaere; D Branellec; B Schwartz; D Scherman
Journal:  Proc Natl Acad Sci U S A       Date:  1999-04-13       Impact factor: 11.205

7.  Gene gun-based nucleic acid immunization: elicitation of humoral and cytotoxic T lymphocyte responses following epidermal delivery of nanogram quantities of DNA.

Authors:  T M Pertmer; M D Eisenbraun; D McCabe; S K Prayaga; D H Fuller; J R Haynes
Journal:  Vaccine       Date:  1995       Impact factor: 3.641

8.  Efficient and regulated erythropoietin production by naked DNA injection and muscle electroporation.

Authors:  G Rizzuto; M Cappelletti; D Maione; R Savino; D Lazzaro; P Costa; I Mathiesen; R Cortese; G Ciliberto; R Laufer; N La Monica; E Fattori
Journal:  Proc Natl Acad Sci U S A       Date:  1999-05-25       Impact factor: 11.205

9.  A combination vaccine confers full protection against co-infections with influenza, herpes simplex and respiratory syncytial viruses.

Authors:  A M Talaat; R Lyons; S A Johnston
Journal:  Vaccine       Date:  2001-11-12       Impact factor: 3.641

Review 10.  Induction of immune responses by DNA vaccines in large animals.

Authors:  L A Babiuk; R Pontarollo; S Babiuk; B Loehr; S van Drunen Littel-van den Hurk
Journal:  Vaccine       Date:  2003-01-30       Impact factor: 3.641

View more
  50 in total

Review 1.  Avian influenza pandemic preparedness: developing prepandemic and pandemic vaccines against a moving target.

Authors:  Neetu Singh; Aseem Pandey; Suresh K Mittal
Journal:  Expert Rev Mol Med       Date:  2010-04-29       Impact factor: 5.600

Review 2.  Effect of vaccine administration modality on immunogenicity and efficacy.

Authors:  Lu Zhang; Wei Wang; Shixia Wang
Journal:  Expert Rev Vaccines       Date:  2015-08-27       Impact factor: 5.217

3.  Cross reactivity of serum antibody responses elicited by DNA vaccines expressing HA antigens from H1N1 subtype influenza vaccines in the past 30 years.

Authors:  Iman Almansour; Huaiqing Chen; Shixia Wang; Shan Lu
Journal:  Hum Vaccin Immunother       Date:  2013-07-24       Impact factor: 3.452

4.  Increased humoral immunity by DNA vaccination using an α-tocopherol-based adjuvant.

Authors:  Ingrid Karlsson; Marie Borggren; Jens Nielsen; Dennis Christensen; Jim Williams; Anders Fomsgaard
Journal:  Hum Vaccin Immunother       Date:  2017-06-14       Impact factor: 3.452

5.  A consensus-hemagglutinin-based DNA vaccine that protects mice against divergent H5N1 influenza viruses.

Authors:  Ming-Wei Chen; Ting-Jen Rachel Cheng; Yaoxing Huang; Jia-Tsrong Jan; Shiou-Hwa Ma; Alice L Yu; Chi-Huey Wong; David D Ho
Journal:  Proc Natl Acad Sci U S A       Date:  2008-09-02       Impact factor: 11.205

6.  Labelling of mammalian cells for visualisation by MRI.

Authors:  Monique R Bernsen; Amber D Moelker; Piotr A Wielopolski; Sandra T van Tiel; Gabriel P Krestin
Journal:  Eur Radiol       Date:  2009-08-12       Impact factor: 5.315

7.  Identification of Aim2 as a sensor for DNA vaccines.

Authors:  John J Suschak; Shixia Wang; Katherine A Fitzgerald; Shan Lu
Journal:  J Immunol       Date:  2014-12-08       Impact factor: 5.422

Review 8.  Technical transformation of biodefense vaccines.

Authors:  Shan Lu; Shixia Wang
Journal:  Vaccine       Date:  2009-11-05       Impact factor: 3.641

9.  Specific humoral immunity versus polyclonal B cell activation in Trypanosoma cruzi infection of susceptible and resistant mice.

Authors:  Marianne A Bryan; Siobhan E Guyach; Karen A Norris
Journal:  PLoS Negl Trop Dis       Date:  2010-07-06

Review 10.  Progress on the induction of neutralizing antibodies against HIV type 1 (HIV-1).

Authors:  Michael Vaine; Shan Lu; Shixia Wang
Journal:  BioDrugs       Date:  2009       Impact factor: 5.807

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.